Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Caribou to slash preclinical allogeneic CAR-NK work, lay off 12% of staff
9 months ago
R&D
Cell/Gene Tx
Metagenomi science chief departs, just a few months after IPO
10 months ago
Startups
Mikael Dolsten isn’t the only one moving on from Pfizer; Lilly names interim finance chief
10 months ago
Peer Review
Roche's gene therapy biotech Spark is laying off employees, ending some early-stage programs
10 months ago
Cell/Gene Tx
JPM’s life sciences VC team is growing
10 months ago
Ten biotech executives who reaped the biggest M&A windfalls, netting $40M+ exit packages
10 months ago
Deals
Novartis to shut down San Diego technical research and development facility
10 months ago
AbbVie CSO Tom Hudson to retire, replaced by medical chief
10 months ago
R&D
The best-paying biotechs in the Bay Area, Boston and San Diego for 2023
10 months ago
How the world's biggest pharma and biotech companies paid their typical worker in 2023
10 months ago
Pharma
Who pays the most (and least) in biopharma? We analyzed median pay at 177 companies
10 months ago
Pharma
Biopharma’s 20 highest-paid CEOs of 2023, earning $20M+ pay packages
10 months ago
Pfizer CSO Mikael Dolsten to depart after 15 years leading drug giant's R&D
10 months ago
Apollomics plans to lay off staff, narrow focus for lung cancer trial
10 months ago
R&D
Following a pivotal trial fail and layoffs, Ovid finds itself in a familiar spot
10 months ago
R&D
Takeda to lay off more employees in Massachusetts
10 months ago
Pharma
Aerovate plans to lay off nearly all employees after trial failure
10 months ago
R&D
Pharma
Q&A: Vertex’s pain research chief on moving beyond opioids, AI and how pharma acquisitions thrive or fail
10 months ago
R&D
Ginkgo to cut at least 35% of staff in multi-year restructuring plan
10 months ago
Pharma
Biopharma leaders charting a path for the industry's LGBTQ+ community
10 months ago
Special
Lilly cracks down further on compounded tirzepatide as GLP-1 shortage starts to ease
10 months ago
Law
Stephen Squinto talks writing checks and next-gen obesity drugs as JP Morgan closes first $500M+ biotech fund
11 months ago
Financing
Bill Haney gives up CEO post at Skyhawk, becomes chairman; Bayer parts ways with head of biotech
11 months ago
Peer Review
Barinthus Bio to lay off 25% of its workforce and focus on just two programs
11 months ago
R&D
First page
Previous page
8
9
10
11
12
13
14
Next page
Last page